MedMira Inc
Research MedMira Inc (47M) on Bullrun: market cap EUR 25.96M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker47M
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 25.96M
- Financial periodQ1 2026
- RevenueEUR 24.50K
- Net income-EUR 657.55K
- Free cash flow-EUR 267.69K
- Gross margin74.0%
Valuation Snapshot
latest market cap is EUR 25.96M.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis;
Frequently asked questions
What is MedMira Inc's market cap?
MedMira Inc's market capitalization is EUR 25.96M.
What does MedMira Inc do?
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma;